Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

Simple item page
dc.contributor.authorOfori-Adjei, D.
dc.contributor.authorDodoo, A.N.
dc.contributor.authorFogg, C.
dc.contributor.authorAsiimwe, A.
dc.contributor.authorNartey, E.T.
dc.contributor.authorKodua, A.
dc.contributor.authorTenkorang, O.
dc.date.accessioned2018-09-25T09:22:21Z
dc.date.available2018-09-25T09:22:21Z
dc.date.issued2009
dc.descriptionArticleen_US
dc.description.abstractChange of first-line treatment of uncomplicated malaria to artemisinin-combination therapy (ACT) is widespread in Africa. To expand knowledge of safety profiles of ACT, pharmacovigilance activities are included in the implementation process of therapy changes. Ghana implemented first-line therapy of artesunate-amodiaquine in 2005. Drug utilization data is an important component of determining drug safety, and this paper describes how anti-malarials were prescribed within a prospective pharmacovigilance study in Ghana following anti-malarial treatment policy change.en_US
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/24340
dc.language.isoenen_US
dc.publisherMalar Journalen_US
dc.subjectDrug Utilizationen_US
dc.subjectTreatmenten_US
dc.subjectArtemisinin-Combination Therapyen_US
dc.titlePattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapyen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Surgery